Middle East & Africa Dupuytren’s Disease Market Size & Outlook
Related Markets
MEA dupuytren’s disease market highlights
- The MEA dupuytren’s disease market generated a revenue of USD 125.7 million in 2022.
- The market is expected to grow at a CAGR of 5.6% from 2023 to 2030.
- In terms of segment, type ii was the largest revenue generating disease type in 2022.
- Type II is the most lucrative disease type segment registering the fastest growth during the forecast period.
- Country-wise, UAE is expected to register the highest CAGR from 2023 to 2030.
MEA data book summary
| Market revenue in 2022 | USD 125.7 million |
| Market revenue in 2030 | USD 193.8 million |
| Growth rate | 5.6% (CAGR from 2022 to 2030) |
| Largest segment | Type ii |
| Fastest growing segment | Type II |
| Historical data covered | 2018 - 2021 |
| Base year for estimation | 2022 |
| Forecast period covered | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Type I, Type II, Type III |
| Key market players worldwide | Bayer AG, Novartis AG ADR, Pfizer Inc, Bristol-Myers Squibb Co, GSK PLC, AstraZeneca PLC, Hikma Pharmaceuticals PLC, LEO Pharma, Fresenius SE & Co KGaA, Nantong Jinghua Pharmaceutical, Actiza Pharmaceutical Pvt. Ltd, Eppendorf, Endo Pharmaceuticals, Spear Pharmaceuticals |
Other key industry trends
- In terms of revenue, MEA region accounted for 3.0% of the global dupuytren’s disease market in 2022.
- Globally, Asia Pacific is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 2,533.8 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Dupuytren’s Disease Market Scope
Dupuytren’s Disease Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Spear Pharmaceuticals | View profile | - | Randolph, New Jersey, United States, North America | http://www.spearpharma.com/ |
| Actiza Pharmaceutical Pvt. Ltd | View profile | 11-50 | https://www.actizapharma.com/ | |
| Nantong Jinghua Pharmaceutical | View profile | 1001-5000 | Nantong, Jiangsu, China, Asia | http://www.jinghuapharm.com/ |
| Hikma Pharmaceuticals PLC | View profile | 2150 | 1 New Burlington Place, London, United Kingdom, W1S 2HR | https://www.hikma.com |
| Endo Pharmaceuticals | View profile | 1001-5000 | Ballsbridge, Dublin, Ireland, Europe | http://www.endo.com |
| Eppendorf | View profile | 1001-5000 | Hamburg, Hamburg, Germany, Europe | https://dasgip.de |
| LEO Pharma | View profile | 1001-5000 | Parsippany, New Jersey, United States, North America | http://www.leo-pharma.us/ |
| AstraZeneca PLC | View profile | 89900 | 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, United Kingdom, CB2 0AA | https://www.astrazeneca.com |
| Bayer AG | View profile | 99723 | Kaiser-Wilhelm-Allee 1, Leverkusen, NW, Germany, 51368 | https://www.bayer.com |
| GSK PLC | View profile | 70200 | 980 Great West Road, Brentford, Middlesex, United Kingdom, TW8 9GS | https://www.gsk.com |
| Bristol-Myers Squibb Co | View profile | 34100 | Route 206 and Province Line Road, Princeton, New Jersey, NJ, United States, 08543 | https://www.bms.com |
| Fresenius SE & Co KGaA | View profile | 193865 | Else-Kroener-Strasse 1, Bad Homburg, HE, Germany, 61352 | https://www.fresenius.com |
| Pfizer Inc | View profile | 88000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | https://www.pfizer.com |
| Novartis AG ADR | View profile | 76057 | Lichtstrasse 35, Basel, Switzerland, 4056 | https://www.novartis.com |
Middle East & Africa dupuytren’s disease market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to dupuytren’s disease market will help companies and investors design strategic landscapes.
Type ii was the largest segment with a revenue share of 62.53% in 2022. Horizon Databook has segmented the Middle East & Africa dupuytren’s disease market based on type i, type ii, type iii covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to Middle East & Africa dupuytren’s disease market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Middle East & Africa dupuytren’s disease market databook
-
Our clientele includes a mix of dupuytren’s disease market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa dupuytren’s disease market, including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa dupuytren’s disease market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
MEA dupuytrens disease market report size, by country, 2018-2030 (US$M)
Middle East & Africa Dupuytren’s Disease Market Share, 2022 & 2030 (US$M)
Related industry reports
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
